Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

101 (47%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NAPROXEN 500MG TABLET Resolved 2024-12-19 2025-02-28 246095
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176779
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176794
TEVA-NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-09 190740
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-06-08 2023-06-21 194094
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2021-10-14 2022-02-17 147219
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-12-02 2022-02-10 150403
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-07-04 2023-07-14 197052
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-10-05 2023-12-14 206392
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2024-01-11 2024-03-18 215719
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2024-11-08 2025-01-09 242341
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2021-10-21 2021-11-05 147708
TEVA-NAPROXEN SODIUM DS 550MG TABLET Actual shortage 2025-04-24 2025-04-24 255684
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2023-10-19 2023-11-09 207509
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2022-05-05 2022-06-04 160072
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2020-06-25 2020-07-23 118954
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2020-04-03 2020-04-09 110752
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2021-01-22 2021-03-18 132257
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Discontinued 2025-10-22 2025-10-22 257579
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173